| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |